AXGN FY 2020 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

FY 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$112M+5.2% YoY

Gross Profit

$91M80.8% margin

Operating Income

-$23M-20.6% margin

Net Income

-$24M-21.2% margin

EPS (Diluted)

$-0.60

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$32M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$201M

Total Liabilities

$78M

Stockholders' Equity

$123M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$112M	$107M	+5.2%
Gross Profit	$91M	$89M	+1.5%
Operating Income	-$23M	-$31M	+26.2%
Net Income	-$24M	-$29M	+18.3%